Page results
- 
                                    
                                                                            UCLH is to trial a COVID-19 vaccine developed by Imperial College London. 
- 
                                    
                                                                            UCLH will play a vital role in a new respiratory virus study. 
- 
                                    
                                                                            Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH. 
- 
                                    
                                                                            UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding. 
- 
                                    
                                                                            Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff. 
- 
                                    
                                                                            It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata! 
- 
                                    
                                                                            UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals. 
- 
                                    
                                                                            UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021. 
- 
                                    
                                                                            As a mark of respect for the funeral of Her Majesty The Queen on Monday 19 September, we are postponing our Annual Members’ Meeting, which was scheduled for this date. 
- 
                                    
                                                                            A tribute to Her Majesty The Queen 
File results
- 
                                                                            FOI/2023/0950 - Trust membership of Stonewall's Diversity Champion programme 
- 
                                                                            FOI/2023/0938 - Trust pain management education provided to staff 
- 
                                                                            FOI/2023/0923 - Proton Beam Therapy treatments 
- 
                                                                            FOI/2019/241 Acute Stoke Units in London 
- 
                                                                            FOI/2023/0833 - Evaluation of outpatient referrals to neurosurgical department 
- 
                                                                            FOI/2023/0821 - SME suppliers the public sector purchases 
- 
                                                                            FOI/2023/0814 - Wound dressings containing chitosan 
- 
                                                                            FOI/2023/0810 - Inflammatory Bowel Disease colorectal cancer colonoscopy surveillance endoscopy 
- 
                                                                            FOI/2023/0769 - Patients with Inflammatory Bowel Disease/ Small Intestinal Bacterial Overgrowth (SIBO) 
- 
                                                                            FOI/2023/0761 - Trust EPR system/ clinical data repository